Article
Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors
19 Dec 2012
Abstract excerpt
The human immunodeficiency virus (HIV) enters cells through a series of molecular interactions between the HIV envelope protein and cellular receptors, thus providing many opportunities to block infection. Entry inhibitors are currently being used in the clinic, and many more are under development. Unfortunately, as is the case for other classes of antiretroviral drugs that target later steps in the viral life...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
